Geron | GERN - Market Capitalization


Geron reported $918.1M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 185.28B 33.35B Feb/2026
Bio Techne USD 8.66B 595M Sep/2025
Cassava Sciences USD 86M 55M Feb/2026
Cytokinetics USD 6.58B 2.63B Sep/2025
Exelixis USD 10.79B 1.79B Sep/2025
Genmab DKK 80.88B 7.82B Jun/2025
Geron USD 874M 24M Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
Incyte USD 16.56B 3.38B Sep/2025
MacroGenics USD 114M 8M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025